Flashpoint Therapeutics announces $10M seed financing led by Beta Lab with participation from Russell Carson's CS Venture Opportunities Fund.

Flashpoint nanostructures are all-in-one formulations that kinetically tune and co-deliver precise combinations of therapeutic components. This approach overcomes limitations of current technologies that rely on mixing therapeutic components with little control over their co-delivery or structural presentation.